These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 36765347)

  • 1. What do we know about pathological mechanism and pattern of lung injury related to SARS-CoV-2 Omicron variant?
    Scendoni R; Cingolani M
    Diagn Pathol; 2023 Feb; 18(1):18. PubMed ID: 36765347
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resurgence of SARS-CoV-2 Delta after Omicron variant superinfection in an immunocompromised pediatric patient.
    Alisoltani A; Simons LM; Agnes MFR; Heald-Sargent TA; Muller WJ; Kociolek LK; Hultquist JF; Lorenzo-Redondo R; Ozer EA
    Virol J; 2023 Oct; 20(1):246. PubMed ID: 37891657
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pathogenicity of SARS-CoV-2 Omicron (R346K) variant in Syrian hamsters and its cross-neutralization with different variants of concern.
    Mohandas S; Yadav PD; Sapkal G; Shete AM; Deshpande G; Nyayanit DA; Patil D; Kadam M; Kumar A; Mote C; Jain R
    EBioMedicine; 2022 May; 79():103997. PubMed ID: 35405385
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infection, pathology and interferon treatment of the SARS-CoV-2 Omicron BA.1 variant in juvenile, adult and aged Syrian hamsters.
    Yuan L; Zhu H; Chen P; Zhou M; Ma J; Liu X; Wu K; Chen R; Liu Q; Yu H; Li L; Wang J; Zhang Y; Ge S; Yuan Q; Tang Q; Cheng T; Guan Y; Xia N
    Cell Mol Immunol; 2022 Dec; 19(12):1392-1399. PubMed ID: 36258005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and Pulmonary CT Characteristics of Patients Infected With the SARS-CoV-2 Omicron Variant Compared With Those of Patients Infected With the Alpha Viral Strain.
    Yang N; Wang C; Huang J; Dong J; Ye J; Fu Y; Huang J; Xu D; Cao G; Qian G
    Front Public Health; 2022; 10():931480. PubMed ID: 35903393
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association between immunity and viral shedding duration in non-severe SARS-CoV-2 Omicron variant-infected patients.
    He S; Fang Y; Yang J; Wang W
    Front Public Health; 2022; 10():1032957. PubMed ID: 36620263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of Reinfection with SARS-CoV-2 Omicron Variants in Previously Infected Hamsters.
    Shiwa-Sudo N; Sakai Y; Iwata-Yoshikawa N; Watanabe S; Yamada S; Kuroda Y; Yamamoto T; Shirakura M; Fujisaki S; Miyazaki K; Miura H; Nagata S; Fukushi S; Maeda K; Hasegawa H; Suzuki T; Nagata N
    J Virol; 2023 Jan; 97(1):e0136622. PubMed ID: 36633406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. SARS-CoV-2 Omicron Induces Enhanced Mucosal Interferon Response Compared to other Variants of Concern, Associated with Restricted Replication in Human Lung Tissues.
    Alfi O; Hamdan M; Wald O; Yakirevitch A; Wandel O; Oiknine-Djian E; Gvili B; Knoller H; Rozendorn N; Golan Berman H; Adar S; Vorontsov O; Mandelboim M; Zakay-Rones Z; Oberbaum M; Panet A; Wolf DG
    Viruses; 2022 Jul; 14(7):. PubMed ID: 35891570
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diffuse alveolar damage (DAD) resulting from coronavirus disease 2019 Infection is Morphologically Indistinguishable from Other Causes of DAD.
    Konopka KE; Nguyen T; Jentzen JM; Rayes O; Schmidt CJ; Wilson AM; Farver CF; Myers JL
    Histopathology; 2020 Oct; 77(4):570-578. PubMed ID: 32542743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical features and predictive factors related to liver injury in SARS-CoV-2 Delta and Omicron variant-infected patients.
    Deng H; Lin H; Mai Y; Liu H; Chen W
    Eur J Gastroenterol Hepatol; 2022 Sep; 34(9):933-939. PubMed ID: 35482929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimal Crossover between Mutations Associated with Omicron Variant of SARS-CoV-2 and CD8
    Redd AD; Nardin A; Kared H; Bloch EM; Abel B; Pekosz A; Laeyendecker O; Fehlings M; Quinn TC; Tobian AAR
    mBio; 2022 Apr; 13(2):e0361721. PubMed ID: 35229637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Paraviral cutaneous manifestations associated to SARS-CoV-2 Omicron variant.
    Zupin L; Moltrasio C; Tricarico PM; Del Vecchio C; Fontana F; Marzano AV; Crovella S
    Infect Dis (Lond); 2023 Mar; 55(3):181-188. PubMed ID: 36494183
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Real-life Evidence of Lower Lung Virulence in COVID-19 Inpatients Infected with SARS-CoV-2 Omicron Variant Compared to Wild-Type and Delta SARS-CoV-2 Pneumonia.
    Trunfio M; Portesani F; Vicinanza S; Nespoli P; Traverso F; Cortese G; Bonora S; Calcagno A; Di Perri G
    Lung; 2022 Oct; 200(5):573-577. PubMed ID: 36114845
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of mRNA vaccination-elicited RBD-specific memory B cells reveals strong but incomplete immune escape of the SARS-CoV-2 Omicron variant.
    Sokal A; Broketa M; Barba-Spaeth G; Meola A; Fernández I; Fourati S; Azzaoui I; de La Selle A; Vandenberghe A; Roeser A; Bouvier-Alias M; Crickx E; Languille L; Michel M; Godeau B; Gallien S; Melica G; Nguyen Y; Zarrouk V; Canoui-Poitrine F; Noizat-Pirenne F; Megret J; Pawlotsky JM; Fillatreau S; Simon-Lorière E; Weill JC; Reynaud CA; Rey FA; Bruhns P; Chappert P; Mahévas M
    Immunity; 2022 Jun; 55(6):1096-1104.e4. PubMed ID: 35483354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structural Study of SARS-CoV-2 Antibodies Identifies a Broad-Spectrum Antibody That Neutralizes the Omicron Variant by Disassembling the Spike Trimer.
    Zhan W; Tian X; Zhang X; Xing S; Song W; Liu Q; Hao A; Hu Y; Zhang M; Ying T; Chen Z; Lan F; Sun L
    J Virol; 2022 Aug; 96(16):e0048022. PubMed ID: 35924918
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tracking the time course of pathological patterns of lung injury in severe COVID-19.
    Mauad T; Duarte-Neto AN; da Silva LFF; de Oliveira EP; de Brito JM; do Nascimento ECT; de Almeida Monteiro RA; Ferreira JC; de Carvalho CRR; do Nascimento Saldiva PH; Dolhnikoff M
    Respir Res; 2021 Jan; 22(1):32. PubMed ID: 33514373
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Characteristics and Outcomes Among Adults Hospitalized with Laboratory-Confirmed SARS-CoV-2 Infection During Periods of B.1.617.2 (Delta) and B.1.1.529 (Omicron) Variant Predominance - One Hospital, California, July 15-September 23, 2021, and December 21, 2021-January 27, 2022.
    Modes ME; Directo MP; Melgar M; Johnson LR; Yang H; Chaudhary P; Bartolini S; Kho N; Noble PW; Isonaka S; Chen P
    MMWR Morb Mortal Wkly Rep; 2022 Feb; 71(6):217-223. PubMed ID: 35143466
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comorbidities prolonged viral shedding of patients infected with SARS-CoV-2 omicron variant in Shanghai: A multi-center, retrospective, observational study.
    Pei L; Chen Y; Zheng X; Gong F; Liu W; Lin J; Zheng R; Yang Z; Bi Y; Chen E
    J Infect Public Health; 2023 Feb; 16(2):182-189. PubMed ID: 36566602
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The significant immune escape of pseudotyped SARS-CoV-2 variant Omicron.
    Zhang L; Li Q; Liang Z; Li T; Liu S; Cui Q; Nie J; Wu Q; Qu X; Huang W; Wang Y
    Emerg Microbes Infect; 2022 Dec; 11(1):1-5. PubMed ID: 34890524
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular Pathogenesis of Fibrosis, Thrombosis and Surfactant Dysfunction in the Lungs of Severe COVID-19 Patients.
    Krygier A; Szmajda-Krygier D; Świechowski R; Pietrzak J; Wosiak A; Wodziński D; Balcerczak E
    Biomolecules; 2022 Dec; 12(12):. PubMed ID: 36551272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.